REFERENCES
- Abeshouse BS, Applefeld W. Citrate metabolism in urolithiasis: The role of acetazolamide (Diamox®) in the formation of calculi and calcium deposits in the kidney. Sinai Hosp J 1956; 5: 73.
- Backman U, Danielson BG, Johansson G, Ljunghall S, Wikström B. Incidence and clinical importance of renal tubular defects in recurrent renal stone formers. Nephron 1980; 25: 96.
- Bisaz S, Felix R, Neuman WF, Fleisch H. Quantitative determination of inhibitors of calcium phosphate precipitation in whole urine. Mineral Electrolyte Metab 1978; 1: 74.
- Brenes LG, Brenes JN, Rodriques VM. Familial proximal renal tubular acidosis with hyperexcretion of uric acid. Am Soc Nephrol 1974; 7: 13.
- Brenner RJ, Spring DB, Sebastian A, McSherry EM, Genant HK, Palubinskas AJ, Morris RC Jr. Incidence of radiographically evident bone disease, nephrocalcinosis and nephrolithiasis in various types of renal tubular acidosis. N Engl J Med 1982; 307: 217.
- Fellström B, Backman U, Danielson BG, Johansson G, Ljunghall S, Wikström B. Urinary excretion of urate in renal calcium stone disease and in renal tubular acidification disturbances. J Urol 1982; 127: 589.
- Gebhardt M. Harnsteinanalyse mittels Röntgendiffraktion. In:Vahlensieck W, ed. Urolithiasis 1. Berlin, Heidelberg, New York: Springer-Verlag, 1979: 77–121.
- Goldberg M. The renal physiology of diuretics. In:Orloff J, Berliner SG, eds. Handbook of physiology, Section 8: Renal physiology. Washington: Am Phys Soc, 1973: 1003–1031.
- Gordon EE, Sheps SG. Effect of acetazolamide on citrate excretion and formation or renal calculi. N Engl J Med 1957; 256: 1215.
- Herring LC. Observations on the analysis of ten thousand urinary calculi. J Urol 1962; 88: 545.
- Kass MA, Kolker AE, Gordon M, Goldberg I, Gieser DK, Krupin T, Becker B. Azetazolamide and urolithiasis. Ophthalmology 1981; 88: 261.
- Lang F, Greger R, Sporer H, Oberleithner H, Deetjew P. Renal handling of urate and oxalate: Possible implications for urolithiasis. Urol Res 1979; 7: 143.
- Larsson L, Sörbo B, Tiselius H-G, Öhman S. A method for quantitative wet-chemical analysis of urinary calculi. Clin Chim Acta 1984; 140: 9.
- Mackenzie AR. Acetazolamide-induced renal stone. J Urol 1960; 84: 453.
- Meyer JL, Smith LH. Growth of calcium oxalate crystals. II. Inhibition by natural urinary crystal growth inhibitors. Invest Urol 1975; 13: 36.
- Narins RG, Goldberg M. Renal tubular acidosis: pathophysiology, diagnosis and treatment. In: Dis Mon 26: 6. Year Book Medical Publishers, Chicago, 1977.
- Parfitt AM. Acetazolamide and sodium bicarbonate induced nephrocalcinosis and nephrolithiasis. Arch Intern Med 1969; 124: 736.
- Pepys MB. Acetazolamide and renal stone formation. Lancet 1970; 1: 837.
- Persky L, Chamberg D, Potts A. Calculus formation and ureteric colic following acetazolamide (Diamox) therapy. JAMA 1956; 161: 1625.
- Pohlman T, Hruska KA, Menon M. Renal tubular acidosis. J Urol 1984; 132: 431.
- Roblin RO, Clapp JW. The preparation of ureterocyclic sulfonamides. J Am Chem Soc 1950; 72: 4890.
- Rosen DI. Acetazolamide and urinary stone formation. Virginia Medical Monthly 1976; 103: 363.
- Scheie HG. In Discussion of Leopold IH, Eisenberg IJ, Yasura J. Experiences with Diamox in glaucoma. Am J Ophthalmol 1955; 39: 885.
- Shah A, Constant MA, Becker B. Urinary excretion of citrate in humans following administration of acetazolamide (Diamox). Arch Ophthalmol 1958; 59: 536.
- Simpson DP. Citrate excretion: A window on renal metabolism. Am J Physiol 1983; 244: F223.
- Takemoto M. Prophylaxis for acetazolamide induced urolithiasis: clinical study. Nippon Hinyokika Gakkai Zasshi 1978; 69: 968.
- Tiselius H-G. The effect of pH on the urinary inhibition of calcium oxalate crystal growth. Br J Urol 1981; 53: 470.
- Tiselius H-G. An improved method for the routine biochemical evaluation of patients with recurrent calcium oxalate stone disease. Clin Chim Acta 1982; 122: 409.
- Tiselius H-G. A simplified estimate of the ion-activity product of calcium phosphate in urine. Eur Urol 1984; 10: 191.
- Tiselius H-G, Almgård LE, Larsson L, Sörbo B. A biochemical basis for grouping of patients with urolithiasis. Eur Urol 1978; 4: 241.
- Tiselius H-G, Larsson L. Validity of biochemical findings in the evaluation of patients with urolithiasis. Eur Urol 1980; 6: 90.